03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Dysport 300U : | |
Type | Medicine Authorised |
Originator | Biotech (Dysport 300U) |
Agent | Droguerie de l'Union |
Distributor | Droguerie de l'Union |
Laboratory | Ipsen Pharma |
Responsible Party | Ipsen Ltd |
Origin | UK |
Manufacturer | Ipsen Biopharm Ltd |
Origin | UK |
ATC | M03AX01 |
Dysport 300U :
Dysport 300U :
Dysport 300U :
Dysport 300U :
Dysport 300U :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Dysport 300U :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abdominal pain | Not known |
Alopecia | Common |
Amnesia | Uncommon |
Anaphylaxis | Not known |
Angioedema (Angioneurotic oedema) (Quincke oedema) | Not known |
Angle closure glaucoma | Not known |
Anorexia | Not known |
Arrhythmia | Not known |
Arthralgia (Pain joint) (Joint ache) | Common |
Asthenia | Common |
Atrophy | Not known |
Autonomic dysreflexia | Common |
Bacteriuria | Common |
Bladder diverticulum | Common |
Brachial plexopathy | Not known |
Bursitis | Uncommon |
Cephalea | Common |
Constipation | Common |
Convulsion | Not known |
Coordination disturbance | Uncommon |
Corneal erosion | Very rare |
Corneal perforation | Very rare |
Depression | Uncommon |
Dermatitis | Uncommon |
Dermatitis psoriasiform | Not known |
Diarrhoea (Diarrhea) | Not known |
Diplopia | Uncommon |
Dry eye | Common |
Dry mouth (Xerostomia) | Common |
Dysarthria | Not known |
Dysphagia | Very Common |
Dysphonia | Uncommon |
Dyspnoea (dyspnea) | Uncommon |
Dysuria (Micturition painful) | Very Common |
Ear infection | Very Common |
Ecchymosis | Common |
Ectropion | Uncommon |
Entropion | Uncommon |
Erythema multiforme | Not known |
Eye irritation | Common |
Eyelid oedema | Rare |
Face oedema | Common |
Facial paralysis | Uncommon |
Facial paresis | Common |
Fall | Common |
Fatigue | Common |
Fever | Uncommon |
Flu-like syndrome | Common |
Gait abnormal | Common |
Gait disturbance | Common |
Haematuria (Hematuria) | Common |
Hot flush | Common |
Hyperhidrosis | Common |
Hypertonia | Common |
Hypoacusis | Not known |
Hypoesthesia | Common |
Injection site bleeding | Common |
Injection site hypersensitivity | Common |
Injection site irritation | Common |
Injection site oedema | Common |
Injection site pain | Very Common |
Injection site reaction | Common |
Insomnia | Common |
Keratitis | Uncommon |
Lacrimation increased (Epiphora) | Common |
Lagophthalmos | Common |
Leukocyturia | Common |
Lightheadedness | Common |
Madarosis | Not known |
Malaise | Common |
Migraine | Common |
Muscle atrophy | Not known |
Muscle spasms | Common |
Muscle weakness | Common |
Musculoskeletal stiffness | Common |
Myalgia | Common |
Myasthenia gravis | Not known |
Myocardial infarction | Not known |
Nausea | Common |
Neuropathy peripheral | Not known |
Oedema peripheral | Common |
Orthostatic hypotension | Uncommon |
Pain | Very Common |
Pain in extremity (Pain in limb) | Common |
Paraesthesia (paresthesia) | Common |
Paraesthesia oral | Uncommon |
Photophobia | Common |
Pneumonia aspiration | Not known |
Pollakiuria (Urinary frequency) | Common |
Pruritus | Common |
Ptosis | Very Common |
Punctate keratitis | Common |
Purpura | Common |
Pyrexia | Common |
Radiculopathy | Not known |
Residual urine volume increased | Common |
Respiratory depression | Not known |
Respiratory failure | Not known |
Rhinitis | Common |
Serum sickness | Not known |
Skin Eruption | Common |
Skin odour abnormal | Common |
Skin soreness | Uncommon |
Somnolence | Common |
Strabismus | Not known |
Subcutaneous nodule | Common |
Syncope | Not known |
Tinnitus | Not known |
Ulcerative keratitis (Ulcer corneal) | Very rare |
Upper respiratory tract infection | Common |
Urinary incontinence | Common |
Urinary retention | Very Common |
Urinary tract infection | Very Common |
Urticaria | Not known |
Vertigo | Uncommon |
Viral infection | Very Common |
Vision blurred | Uncommon |
Visual disturbance | Uncommon |
Vomiting | Not known |
Dysport 300U :
▲ Most Expensive |
▼ Least Expensive |
P.P. = | Public Price |
P/U = | Price Per Unit |
- Products with same active ingredients |
- Products with same strength |
- Products with same route of administration |
NB : Products With Same Indication |
Different Units By MoH Code
Dysport 300U MoH 7646 :
Form | Powder for solution for injection |
Packaging | Bottle |
Package Size | Box of 1 |
Strength | 300U |
Public Price | 14625181.9 L.L. |
Stratum | D |
NSSF | ✘ |
Quarantine | ✔ |
Reg. Number | 105914/1 |
Submission date | 01/01/2014 |
Registration Year | 2014 |
Archived Date | 03/05/2023 |
Price Comparison
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
Note
You have to register to view this info
Drop File